Henry P. Parkman MD
Professor of Medicine, Temple University School of Medicine, Philadelphia, PennsylvaniaSince joining the faculty of Temple University School of Medicine in 1990, Dr. Henry Parkman has been involved in studying gastrointestinal motility at both the basic science and clinical levels through his research and clinical practice. Clinically, he is in charge of Temple’s GI Motility Laboratory, which is very active supporting foregut surgeons, bariatric surgeons, and the lung transplantation center. He has an active practice in GI motility and functional GI disorders. At Temple, Dr. Parkman is the Vice Chair for Research in the Department of Medicine and organizes conferences on clinical research.
During his Presidency of the American Neurogastroenterology and Motility Society (ANMS), in addition to holding the biennial scientific meetings, he set up clinical courses on GI motility, funding for research grants, and the clinical training program for GI fellows at Neurogastroenterology Centers of Excellence (one of which is Temple!).
Dr. Parkman is currently a funded member of the NIH Gastroparesis Clinical Research Consortium, which was set up by the NIDDK to enhance understanding of gastroparesis.
Recently, Dr. Parkman was awarded the Stanley Lorber Chair in Gastroenterology, a position that will assist him in further research, particularly with medical students, residents, and GI fellows.
Disclosures
Dr. Parkman reports the following:- Consulting with Industry
- Evoke Pharma
- AEON Biopharma
- Takeda Pharma
- Medtronic Enterra
- Research Grants
- Medtronic - WMC and EndoFlip in gastroparesis
- NIH NIDDK Gastroparesis Clinical Research Consortium
Recent Contributions to PracticeUpdate:
- Value of Gastric Emptying Scintigraphy Parameters in Predicting the Long-Term Success of Gastric Peroral Endoscopic Myotomy in Patients With Gastroparesis
- Endoscopic Pyloromyotomy for the Treatment of Severe and Refractory Gastroparesis
- Drug–Drug Interactions in Gastroparesis Management
- Relationship Between Glycemic Control and Gastric Emptying in Type 2 Diabetes